The health industry has no shortage of charlatans claiming that some magical seeds, flowers, herbs, or even energy are capable of miraculous healing. Now, those swindlers can add actress Gwyneth Paltrow’s company called Goop among their number. The startup was blasted by NASA for claiming that its incredibly expensive healing stickers contained the same materials as astronaut space suits.
At $120 for 24 stickers, these miracle circles of varying colors and patterns are not cheap. However, such is the privilege that Goop believes it has, which the sticker’s creator justifies by saying that it’s made of space-age materials. When NASA decided to call them out on this farce, the company was forced to make a retraction and apologize, BGR reports.
“We apologize to NASA, Goop, our customers and our fans for this communication error,” the statement reads. “We never intended to mislead anyone. We have learned that our engineer was misinformed by a distributor about the material in question, which was purchased for its unique specifications. We regret not doing our due diligence before including the distributor’s information in the story of our product. However, the origins of the material do not anyway impact the efficacy of our product. Body Vibes remains committed to offering a holistic lifestyle tool and we stand by the quality and effectiveness of our product.”
As for NASA, the space agency asserts that the space suits that astronauts wear do not have conductive carbon materials, which are supposedly used as lining for the suits, Consumerist reports. Rather, the suits are made of synthetic polymer and spandex.
Regardless of whether or not the stickers are made of whatever NASA developed for its spacemen, however, Goop is still saying that they are effective at healing. As to whether or not they actually do anything to help consumers, there have been no peer-reviewed studies to indicate one way or another.


NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Tabletop particle accelerator could transform medicine and materials science
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 



